Skip to main content
logo
Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China flag China · Delayed Price · Currency is CNY
5.60
-0.10 (-1.75%)
Sep 3, 2026, 3:00 PM CST

SHA:600223 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
155.36187.75243.53303.3945.46361.9
Depreciation & Amortization
110.51108.6102.23147.76121.694.03
Other Amortization
15.5915.3711.0810.018.017.91
Loss (Gain) From Sale of Assets
0.020.06-0.960.77-0.770.15
Asset Writedown & Restructuring Costs
0.50.170.72.194.744.04
Loss (Gain) From Sale of Investments
-53.13-55.39-63.98-214.34-116.21-201.34
Provision & Write-off of Bad Debts
10.2710.2725.9438.3166.86101.05
Other Operating Activities
61.359.9182.83162.9684.2335.79
Change in Accounts Receivable
-22.31-87.79175.891,861523.122,032
Change in Inventory
0.9119.35-33.91-598.861,899344.74
Change in Accounts Payable
16.33-80.34-308.12-1,228-2,2383,760
Change in Other Net Operating Assets
-----5.59
Operating Cash Flow
291.98276.22228.65474.15998.16,848
Operating Cash Flow Growth
162.12%20.80%-51.78%-52.49%-85.42%53.96%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-87.74-110.42-157.22-211.37-166.11-281.53
Sale of Property, Plant & Equipment
0.190.080.333.895.70.61
Divestitures
-6.73-11.262,9822,641-33.05
Investment in Securities
1.860.0611.68177.5230.83-268.32
Other Investing Activities
44.2462.15155.8562.69130.8164.38
Investing Cash Flow
-48.18-59.382,9932,6731.24-451.81

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-296.323482,70112,6219,931
Total Debt Issued
190.11296.323482,70112,6219,931
Long-Term Debt Repaid
--457.35-2,235-5,281-13,161-15,351
Total Debt Repaid
-364.85-457.35-2,235-5,281-13,161-15,351
Net Debt Issued (Repaid)
-174.74-161.03-1,887-2,580-540.61-5,420
Issuance of Common Stock
----22.4717.05
Common Dividends Paid
-63.57-65.19-183.57-487.96-1,175-2,015
Other Financing Activities
-21.59-20.94-35.02-29.6975.44629.44
Financing Cash Flow
-259.91-247.16-2,106-3,097-1,618-6,789

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.12-0.01-0.23-1.019.82-0.41
Net Cash Flow
-16.23-30.331,11648.93-608.61-393.24

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
204.24165.871.44262.79831.986,567
Free Cash Flow Growth
-132.10%-72.82%-68.41%-87.33%53.04%
Free Cash Flow Margin
5.42%4.54%1.79%5.74%6.42%53.12%
Free Cash Flow Per Share
0.190.160.070.260.736.35
Levered Free Cash Flow
135.9373.023,1062,8791,8372,779
Unlevered Free Cash Flow
139.5876.673,1202,9392,0882,849

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.171.17----
Cash Income Tax Paid
285.58277.93290.52553.181,0991,786
Change in Working Capital
-8.44-50.53-172.7123.18184.26,145